Indication and outcome of hematopoietic stem cell transplantation in primary immunodeficiency with predominant hypogammaglobulinemia – a retrospective study

• Conditions: D80.9; D83.9; Z94.81; Z94.80; Immunodeficiency with predominantly antibody defects, unspecified; Common variable immunodeficiency, unspecified

• Registration Number: DRKS00004296
• Lead Sponsor: Centrum für Chronische Immundefizienz (CCI), Universitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-08-27
• Study Completion: 2013-08-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 31

Inclusion Criteria

adult patients with primary immunodeficiency with predominant antibody deficiency having undergone allogeneic hematopoietic stem cell transplantation before 1st january 2013

Exclusion Criteria

age under 2 at transplantation, no informed consent to data collection

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of adult PAD patients undergoing HSCT for any reason in cooperating centers worldwide.

Secondary Outcome Measures

Name	Time	Method
immune reconstitution, mortality, morbidity after HSCT